RETRACTED ARTICLE: Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study
Authors:
Open Access
- 6 April 2020
- journal article
- retracted article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 18 (1) , 1-11
Abstract
Background: Sphingosine-1-phosphate (S1P) is a signaling phospholipid involved in pathophysiologic progression of acute respiratory distress syndrome (ARDS) through its roles in endothelial barrier function and immune modulation. We hypothesized that decreased serum S1P level is associated with the clinical outcomes of ARDS and polymorphisms in the S1P gene are associated with serum S1P levels. Methods: This multicenter prospective study includes ARDS patients and healthy blood donors as controls. Serum S1P levels were quantified using enzyme-linked immunosorbent assays. Eight tag single nucleotide polymorphisms (SNPs) in the S1P gene were detected, and their associations with S1P levels were evaluated. Results: A total of 121 ARDS patients and 100 healthy individuals were enrolled. Serum S1P levels were lower in ARDS patients than in controls (P < 0.001). Decreased S1P levels correlated with more organ dysfunction and higher Acute Physiology and Chronic Health Evaluation II scores. Changes in S1P levels in ARDS patients were associated with the clinical outcomes. The recessive model for SNP rs3743631 suggests that GG homozygote is associate with a higher risk for ARDS. The dominant model for SNP rs907045 suggests that AA or TA genotype might increase the risk for ARDS. In ARDS patients, the rs3743631 GG genotype showed lower S1P levels than those harboring AG and AA genotypes. The serum S1P levels of rs907045 AA or TA genotype patients were lower than those of TT genotype. Conclusions: Serum S1P levels are dramatically decreased in ARDS patients. Reduced S1P levels are associated with worse clinical outcomes. There is a significant association between S1P rs3743631, rs907045 polymorphisms and susceptibility of ARDS.Keywords
Funding Information
- National Natural Science Foundation of China (81470206, 81670073)
This publication has 34 references indexed in Scilit:
- The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particlesJournal of Lipid Research, 2012
- A Sphingosine 1–Phosphate 1 Receptor Agonist Modulates Brain Death–Induced Neurogenic Pulmonary InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus InfectionCell, 2011
- Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virusProceedings of the National Academy of Sciences, 2011
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 2011
- The Acute Respiratory Distress Syndrome: Pathogenesis and TreatmentAnnual Review of Pathology: Mechanisms of Disease, 2011
- Differential Effects of Sphingosine 1–Phosphate Receptors on Airway and Vascular Barrier Function in the Murine LungAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Vascular Endothelium As a Contributor of Plasma Sphingosine 1-PhosphateCirculation Research, 2008
- Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- APACHE IICritical Care Medicine, 1985